Predicted impact of intravenous thrombolysis. Another trial is needed.
Hoffman
J R
JR
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D018570:Risk Assessment / Q000379:methods; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator